Company Filing History:
Years Active: 2018
Title: Alok Juneja: Innovator in Alzheimer's Disease Research
Introduction
Alok Juneja is a prominent inventor based in Stockholm, Sweden, known for his contributions to the field of molecular biochemistry and medicine. His innovative work focuses on addressing the challenges associated with Alzheimer's disease, particularly through the development of novel ligands.
Latest Patents
Alok Juneja holds a patent titled "Ligands for prevention of neurotoxicity of the Alzheimer's disease related amyloid-beta peptide." This invention relates to ligands comprising modified amino acid residues that target the amyloid-β peptide associated with Alzheimer's disease. The goal of this invention is to prevent aggregation and neurotoxicity, ultimately leading to potential drug treatments for Alzheimer's disease.
Career Highlights
Alok Juneja is affiliated with Alphabeta AB, where he applies his expertise in biochemistry to advance research in neurodegenerative diseases. His work is pivotal in the ongoing quest to find effective treatments for Alzheimer's disease.
Collaborations
Alok collaborates with notable colleagues, including Roger Strömberg and Dmytro Honcharenko, who contribute to the research and development efforts at Alphabeta AB.
Conclusion
Alok Juneja's innovative research and patent contributions are significant in the fight against Alzheimer's disease. His work exemplifies the importance of scientific innovation in addressing complex medical challenges.